Healthcare Contract Development And Manufacturing Organization Market Size, Share & Trends Analysis Report By Services (Contract Development, Contract Manufacturing)- Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2021-2027

The global Healthcare Contract Development And Manufacturing Organization market gathered revenue around USD 201.9 Billion in 2020 and market is set to grow USD 379.7 Billion by the end of 2027 and is estimated to expand at a modest CAGR of 8.1% during the prediction period 2021 to 2027.

Healthcare Contract Development And Manufacturing Organization Market Size 2020 to 2027

Growth Factors:

The market increase in uptake of outsourcing services by pharmaceutical companies and growth in R&D investments are expected to drive the market. Medical devices & pharmaceutical companies are outsourcing low-end services to reduce the overall cost of production. This trend is expected to contribute to the growth of the market for healthcare contract development and manufacturing organization (CDMO), over the forecast period. The presence of end-to-end service providers that offer value-added services for an integrated or risk-sharing business model is expected to bolster market growth.

Healthcare contract development and manufacturing organization (CDMO) provides outsourcing services to various pharmaceutical industries on contract basis. Increase in the outsourcing by pharmaceutical companies, growing pharmaceutical industry, and support of CDMOs in reducing the operational and capital expenses are some of the major factors anticipated to propel the market growth over the forecast period.

In addition, growing pressure on pharmaceutical and medical device companies to follow stringent timelines has increased the demand for outsourcing development and manufacturing activities to CDMOs. Further, due to increasing demand for medical devices in the emerging countries, various companies are shifting their focus on research and development and outsourcing medical devices. Also, rise in outsourcing of R&D and growing competency of CDMOs are expected to further contribute to the growing demand for early-stage development CDMOs by life science companies.

However, increasing logistic costs, serialization issues faced by healthcare organizations, and threat of infringement of Intellectual Property (IP) rights are anticipated to restrain the market growth for healthcare contract development & manufacturing organization over the forecast period.

For pharmaceutical companies, increasing R&D cost is a challenge, which significantly affects their bottom line and therefore they have partnered with CROs & CMOs for integrated outsourcing services. Outsourcing research activities to CMO or CDMO helps accelerate the workflow of companies, provide unique specialized services, decrease drug development costs, and provide the expertise & experience needed for assisting research.

This research report purposes at stressing the most lucrative growth prospects. The aim of the research report is to provide an inclusive valuation of the Healthcare Contract Development And Manufacturing Organization market and it encompasses thoughtful visions, actualities, industry-validated market findings, historic data, and prognoses by means of appropriate set of assumptions and practice. Global Healthcare Contract Development And Manufacturing Organization market report aids in comprehending market structure and dynamics by recognizing and scrutinizing the market sectors and predicted the global market outlook.

Report Coverage

Report Scope Details
Market Size USD 379.7 Billion by 2027
Growth Rate CAGR of 8.1% From 2021 to 2027
Base Year 2020
Forecast Period 2021 to 2027
Historic Data 2017 to 2020
Report coverage Growth Factors, Revenue Status, Competitive Landscape,  and Future Trends
Segments Covered Services And Region
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA)
Companies Mentioned Catalent Inc.; Lonza Group Ltd.; Recipharm AB; Siegfried Holding AG; Thermo Fisher Scientific Inc.; Covance Inc.; Jabil; Sanmina Corporation; IQVIA Holdings Inc.; Flex.

COVID-19 Impact Assessment on Market Landscape

The report comprises the scrutiny of COVID-19 lock-down impact on the income of market leaders, disrupters and followers. Since lock down was instigated differently in diverse regions and nations, influence of same is also dissimilar across various industry verticals. The research report offers present short-term and long-term influence on the market to assist market participants across value chain makers to formulate the framework for short term and long-lasting tactics for recovery and by region.

Healthcare Contract Development And Manufacturing Organization market Report empowers readers with all-inclusive market intelligence and offers a granular outline of the market they are operational in. Further this research study delivers exceptional combination of tangible perceptions and qualitative scrutiny to aid companies accomplishes sustainable growth. This report employs industry-leading research practices and tools to assemble all-inclusive market studies, intermingled with pertinent data. Additionally, this report also emphases on the competitive examination of crucial players by analyzing their product portfolio, pricing, gross margins, financial position, growth approaches, and regional occurrence.

Regional analysis:

North America dominated the healthcare contract development and manufacturing organization market and held the highest revenue share of 42.0% in 2020, which was attributed to the presence of advanced medical infrastructure, lower costs, and growing demand for medical devices in the region. The growth of the pharmaceutical industry further propelled the demand for contract development and manufacturing in the region. Hence, North America’s market is expected to experience lucrative growth in terms of contract development and manufacturing of medical devices.

The regulatory framework in the EU is expected to be subjected to major changes, which may affect market access or entry. The market for healthcare contract development and manufacturing organization is expected to grow lucratively in this region due to stringent regulatory policies. In addition, the EU MDR, which came into effect in May 2017, has made it mandatory for manufacturers to monitor the quality, performance, and quality of their medical devices. This is anticipated to propel the market during the forecast period. The presence of established market players, coupled with superior manufacturing capabilities, is anticipated to drive the market over the forecast period. Furthermore, increasing investments by multinational companies are anticipated to boost the market for healthcare contract development and manufacturing organization.

Asia Pacific is expected to witness the fastest CAGR of 9.2% over the forecast period due to increasing regulatory focus on quality control for manufacturing medical devices, especially in emerging economies such as China and India. In addition, growing medical tourism in emerging economies is expected to drive market in Asia Pacific. The Middle East and Africa and Latin American markets are projected to exhibit lucrative growth soon due to rapidly growing healthcare industries.

Competitive Rivalry

Foremost players in the market are attentive on adopting corporation strategies to enhance their market share. Some of the prominent tactics undertaken by leading market participants in order to sustain the fierce market completion include collaborations, acquisitions, substantial spending in R&D and the improvement of new-fangled products or reforms among others.

Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.

  • Company Overview
  • Company Market Share/Positioning Analysis
  • Product Offerings
  • Financial Performance
  • Recent Initiatives
  • Key Strategies Adopted by Players
  • Vendor Landscape
  • List of Suppliers
  • List of Buyers

Some of the prominent players in the Healthcare Contract Development And Manufacturing Organization Market include:  Catalent Inc.; Lonza Group Ltd.; Recipharm AB; Siegfried Holding AG; Thermo Fisher Scientific Inc.; Covance Inc.; Jabil; Sanmina Corporation; IQVIA Holdings Inc.; Flex

Unravelling the Critical Segments

This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:

  • By Services
    • Contract development
      • Small Molecule
        • Preclinical
          • Bioanalysis and DMPK studies
          • Toxicology Testing
          • Other Preclinical Services
        • Clinical
          • Phase I
          • Phase II
          • Phase III
          • Phase IV
        • Laboratory Services
          • Bioanalytical Services
          • Analytical Services
      • Large Molecule
        • Cell Line development
        • Process Development
          • Upstream
            • Microbial
            • Mammalian
            • Others
          • Downstream
            • MABs
            • Recombinant proteins
            • Others
        • Others
    • Contract manufacturing
      • Small Molecule
      • Large Molecule
        • MABs
        • Recombinant proteins
        • Others
      • High Potency API
      • Finished Dose Formulations
        • Solid Dose Formulation
        • Liquid Dose Formulation
        • Injectable Dose Formulation
      • Medical Devices
        • Class I
        • Class II
        • Class III

By Geography

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • United Kingdom
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Southeast Asia
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Rest of Latin America

Middle East & Africa (MEA)

  • GCC
  • North Africa
  • South Africa
  • Rest of Middle East & Africa

Highlights of the Report:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the market.
  • Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the market
  • Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market
  • Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the market

Research Methodology

In the study, a unique research methodology is utilized to conduct extensive research on the growth of the Healthcare Contract Development And Manufacturing Organization market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the Healthcare Contract Development And Manufacturing Organization market study are as follows - statistics from government organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, all of whom have contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the market, and makes the projections on the growth prospects of the Healthcare Contract Development And Manufacturing Organization markets more accurate and reliable.

Secondary Research

It involves company databases such as Hoover's: This assists us recognize financial information, structure of the market participants and industry competitive landscape.

The secondary research sources referred in the process are as follows:

  • Governmental bodies, and organizations creating economic policies
  • National and international social welfare institutions
  • Company websites, financial reports and SEC filings, broker and investor reports
  • Related patent and regulatory databases
  • Statistical databases and market reports
  • Corporate Presentations, news, press release, and specification sheet of Manufacturers

Primary Research

Primary research includes face-to face interviews, online surveys, and telephonic interviews.

  • Means of primary research: Email interactions, telephonic discussions and Questionnaire based research etc.
  • In order to validate our research findings and analysis we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.

Industry participants involved in this research study include:

  • CEOs, VPs, market intelligence managers
  • Procuring and national sales managers technical personnel, distributors and resellers
  • Research analysts and key opinion leaders from various domains

Key Points Covered in Healthcare Contract Development And Manufacturing Organization market Study:

  • Growth of Healthcare Contract Development And Manufacturing Organization in 2021
  • Market Estimates and Forecasts (2017-2027)
  •  Brand Share and Market Share Analysis
  •  Key Drivers and Restraints Shaping Market Growth
  •  Segment-wise, Country-wise, and Region-wise Analysis
  •  Competition Mapping and Benchmarking
  •  Recommendation on Key Winning Strategies
  •  COVID-19 Impact on Demand for Healthcare Contract Development And Manufacturing Organization and How to Navigate
  •  Key Product Innovations and Regulatory Climate
  • Report Detail

    • Report Code:5894
    • No. of Pages:150+
    • Format:PDF/PPT/Excel

    Proceed To Buy

    USD 3500
    USD 7000

© Copyright 2022, All rights reserved. Nova One Advisor